LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 49 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,641 | +26.2% | 1,175 | 0.0% | 0.00% | – |
| Q2 2023 | $3,678 | -30.9% | 1,175 | 0.0% | 0.00% | – |
| Q1 2023 | $5,323 | +9.7% | 1,175 | 0.0% | 0.00% | – |
| Q4 2022 | $4,853 | +21.3% | 1,175 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 1,175 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 1,175 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -61.5% | 1,175 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -7.1% | 1,175 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | +16.7% | 1,175 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -29.4% | 1,175 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | -32.0% | 1,175 | 0.0% | 0.00% | – |
| Q4 2020 | $25,000 | +38.9% | 1,175 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | +20.0% | 1,175 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | – | 1,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |